Having delivered impressive interim trial data from their Phase 2 clinical trials for a treatment targeting incurable bone marrow cancer, the US Food & Drug Administration (FDA) could soon be the next stop for biopharmaceuticals company Pharmaxis (ASX: PXS) fresh off their poster presentation at the American Society of Hematology (ASH) conference. Hosted in New
Read More
In the mood for some NICE advice? Here goes: The UK’s National Institute for Health and Care Excellence (NICE) has published a MedTech Innovation Briefing on PromarkerD, i.e. a predictive blood test determining diabetes kidney disease (DKD). The Briefing, dubbed NICE advice, reports that PromarkerD is effective at predicting renal function decline in people with
Read More
If childcare occupancy rate is an indicator that the pandemic has come to an end, then the recent announcement from G8 Education (ASX: GEM) indicates that we are one step closer. The childcare education provider reported a core occupancy rate of 77.3%, which is a 1% improvement from CY21. This brings the company closer to
Read More
In Australia, high-contact sports, like football, rugby and such, have some of the highest head injury rates in the world. There’s an average of five injuries per team per season, no matter how intense the competition. To add to that, whether these head injuries lead to concussions cannot be ascertained instantly. Symptoms might take anywhere
Read More
A new bid for sustainable tech is here. So you’ve heard of watches powered by batteries, hand winding and solar energy. Now, make way for watches, among other electronic wearable devices, to be powered by the moisture in the air (unsure whether spit or warm breaths count). Research services company Australian Advanced Materials (AAM) and
Read More
The holiday period has been famous as the time of the year when passengers need to brace themselves at the airport and prepare for the worst – coming way earlier than they should because there will be lines everywhere! This might sound like the worst case scenario, but is less likely to happen in the
Read More
Upon his appointment in August this year, Live Verdure (ASX: LV1) CEO and former Managing Director of Loreal, Mark Tucker, had stated, “The foundations are in place, and the time is right to deliver results for shareholders and stakeholders.” It looks like he is a man of his word. A testament to his tenure, the
Read More
Ending the year on a high, Aussie ESG tech company K2Fly (ASX: K2F) has secured an order from London-based global miner Anglo American, which has a market cap of over $75 billion. Put in perspective, K2Fly’s market cap stands closer to about $30 million. The Company will provide its Mineral Resource Governance Solution, Resource Disclosure,
Read More
The phrase ‘bigger is better’ has never been more appropriate than in the case of PlaySide Studio’s (ASX: PLY) latest venture. After months of negotiations, the Melbourne-based independent games studio has managed to sign a deal with global streaming juggernaut Netflix to develop and release its new game titled Dumb Ways to Survive (DWTS) on
Read More
With hospitals at large struggling to retain staff following the pandemic, healthcare companies like Healius (ASX: HLS) have had to reevaluate their portfolio and cut their losses. So, four years after acquiring it, Healius has decided to let go of Montserrat Day Hospitals based in North Lake, Australia. The Company has entered into a binding
Read More
